6Birsen U,Gulten A,Nicholas P,et al.Mitoxantrone and cytosine arabinoside as first-line induction therapy in newly diagnosed acute nonlymphocytic leukemia.Current Therapeutic Research.1994,55(5):552-558.
7Gandhi V,Estey E,Keating MJ,et al.Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy.J Clin Oncol,1993,11:116-124.
8Ossenkoppele E J,Graveland WJ,Sonneveld P,et al.The value of fludarabine in addition toAra-C and G-CSF in the treatment of patientswith high-riskmy-elodysplastic syndromes and AML in elderly patients.Blood,2004,103:2908-2913.
9Hubeek I,Litvinova E,Peters GJ,et al.The effect of G-CSF on the in vitro cytotoxicity of cytarabine and fludarabine in the FLAG combination in pediat-ric acute myeloid leukemia.Int J Onco1,2004,25:1823-1829.
10Gazitt Y.Homing and mobilization of hematopoietic stem cells and hematopoi-etic cancer cells are mirror image processes,utilizing similar signaling pathways and occurring concurrently:circulating cancer cells constitute an ideal target for concurrent treatmentwith chemotherapy and antilineage-specific antibodies.Leukemia,2004,18:1-10.
